3例肺纤维化患者临床抗纤维化治疗的药学监护

Pharmaceutical Care of Clinical Anti-fibrosis Therapy in 3 Patients with Pulmonary Fibrosis

目的:分析肺纤维化患者抗纤维化治疗的药学监护重点及其成效。方法:临床药师参与3例肺纤维化患者临床治疗,协助医师个性化地调整治疗方案,并针对不同药物针对性开展药学监护。结果与结论:临床药师通过药学监护的开展,及时发现并解决了肺纤维化患者在治疗过程中潜在或实际存在的用药问题,保障了临床用药的安全性和合理性。

Objective:To analyze key points and effectiveness of pharmaceutical care of anti-fibrosis therapy in patients with pulmonary fibrosis.Methods:Clinical pharmacists participated in the clinical treatment of 3 patients with pulmonary fibrosis,assisted physicians in personalizing treatment regimens and provided specific pharmaceutical care for different drugs.Results and Conclusion:Through pharmaceutical care,clinical pharmacists timely identified and solved potential or actual medication problems in the treatment of patients with pulmonary fibrosis,ensuring the safety and rationality of clinical medication.